Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma.
Auteurs : Krayem M, Najem A, Journe F, Morandini R, Sales F, Awada A, Ghanem G Jaar : 2018 Journal : Oncotarget
p53 Reactivation by PRIMA-1 Met (APR-246) sensitises V600E/K BRAF melanoma to vemurafenib.
Auteurs : Krayem M, Journe F, Wiedig M, Morandini R, Najem A, Sales F, Van Kempen LC, Sibille C, Awada A, Marine JC, Ghanem G Jaar : 2016 Journal : Eur J Cancer
Survey on skin-lightening practices and cosmetics in Kigali, Rwanda.
Auteurs : Kamagaju L, Morandini R, Gahongayire F, Stévigny C, Ghanem G, Pirotte G, Duez P Jaar : 2016 Journal : Int. J. Dermatol.
Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model.